Neuroone Medical Technologies Corp (NMTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has a cash flow conversion efficiency ratio of -0.247x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.33 Million) by net assets ($5.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Neuroone Medical Technologies Corp worth for the company's overall valuation and market capitalisation.
Neuroone Medical Technologies Corp - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Neuroone Medical Technologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their cash flow conversion efficiency. Explore earnings quality score of Neuroone Medical Technologies Corp to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sarama Resource
V:SWA
|
0.426x |
|
G.M. LEATHER S.P.A.
F:N78
|
N/A |
|
Kingsrose Mining Ltd
AU:KRM
|
-0.189x |
|
AAA Technologies Limited
NSE:AAATECH
|
0.015x |
|
Holista Colltech Ltd
AU:HCT
|
-0.382x |
|
PT Mitra Pack Tbk
JK:PTMP
|
-0.087x |
|
The Grob Tea Company Limited
NSE:GROBTEA
|
-0.064x |
|
KYM Holdings Bhd
KLSE:8362
|
-0.075x |
Annual Cash Flow Conversion Efficiency for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025. View Neuroone Medical Technologies Corp stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $7.07 Million | $-2.84 Million | -0.401x | +97.01% |
| 2024-09-30 | $822.01K | $-11.01 Million | -13.396x | -549.64% |
| 2023-09-30 | $6.25 Million | $-12.89 Million | -2.062x | -163.38% |
| 2022-09-30 | $9.60 Million | $-7.52 Million | -0.783x | +40.35% |
| 2021-09-30 | $6.55 Million | $-8.60 Million | -1.313x | +20.82% |
| 2020-09-30 | $2.07 Million | $-3.43 Million | -1.658x | -138.02% |
| 2019-09-30 | $-1.24 Million | $-5.40 Million | 4.360x | +577.83% |
| 2018-09-30 | $-4.40 Million | $-2.83 Million | 0.643x | +711.35% |
| 2017-09-30 | $-266.22K | $-21.11K | 0.079x | -78.63% |
| 2016-09-30 | $-81.49K | $-30.23K | 0.371x | -49.84% |
| 2015-09-30 | $-35.39K | $-26.17K | 0.740x | -16.60% |
| 2014-09-30 | $-28.30K | $-25.09K | 0.887x | +11.30% |
| 2013-09-30 | $-17.24K | $-13.73K | 0.797x | 0.00% |
| 2012-09-30 | $-17.24K | $-13.73K | 0.797x | -90.48% |
| 2011-09-30 | $-3.28K | $-27.43K | 8.370x | +610.58% |
| 2010-09-30 | $-4.32K | $-5.09K | 1.178x | -- |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more